Journal
ALZHEIMERS & DEMENTIA
Volume 18, Issue 1, Pages 10-28Publisher
WILEY
DOI: 10.1002/alz.12366
Keywords
Alzheimer's disease; amyloid; Boston criteria; cerebral amyloid angiopathy; immunotherapy intracerebral hemorrhage; meta-analysis; microbleeds; MRI; neuropathology; prevalence; systematic review
Categories
Funding
- ZonMW [733050822, 015008048]
- National Institutes of Health [5R01NS104147-02]
- Selfridges Group Foundation [NR170024]
- DutchHeart Foundation [2012T077, 2019T060]
- Netherlands Organization for Health Research and Development [015008048]
Ask authors/readers for more resources
Reported prevalence estimates of sporadic cerebral amyloid angiopathy (CAA) vary widely, with differences observed in AD patients and the general population. The study found that CAA prevalence based on pathology is higher than that based on presence of strictly lobar cerebral microbleeds. Both methods yield similar estimated prevalences in cognitively normal elderly, patients with intracerebral hemorrhage, and patients with lobar intracerebral hemorrhage. However, large heterogeneity among neuropathology and MRI protocols calls for standardized assessment and reporting of CAA.
Reported prevalence estimates of sporadic cerebral amyloid angiopathy (CAA) vary widely. CAA is associated with cognitive dysfunction and intracerebral hemorrhage, and linked to immunotherapy-related side-effects in Alzheimer's disease (AD). Given ongoing efforts to develop AD immunotherapy, accurate estimates of CAA prevalence are important. CAA can be diagnosed neuropathologically or during life using MRI markers including strictly lobar microbleeds. In this meta-analysis of 170 studies including over 73,000 subjects, we show that in patients with AD, CAA prevalence based on pathology (48%) is twice that based on presence of strictly lobar cerebral microbleeds (22%); in the general population this difference is three-fold (23% vs 7%). Both methods yield similar estimated prevalences of CAA in cognitively normal elderly (5% to 7%), in patients with intracerebral hemorrhage (19% to 24%), and in patients with lobar intracerebral hemorrhage (50% to 57%). However, we observed large heterogeneity among neuropathology and MRI protocols, which calls for standardized assessment and reporting of CAA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available